Fig. 1. The number of fluconazole- and itraconazole-related adverse events reported to the Korean Pharmaceutical Association for Patient and Drug Safety Regional Pharmacovigilance Center over a 10-year period (January 2013-April 2022).

Korean J Clin Pharm 2022;32:204-14 https://doi.org/10.24304/kjcp.2022.32.3.204

© 2022 Korean J Clin Pharm